Rani Therapeutics LLC (RANI)

New Form 8-K - Rani Therapeutics Holdings, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070344 Size: 481 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Hyperfine Inc (HYPR)

New Form 8-K - Hyperfine, Inc. Filed: 2025-05-13 AccNo: 0000950170-25-070340 Size: 568 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Vaxart Inc (VXRT)

New Form 8-K - Vaxart, Inc. Filed: 2025-05-13 AccNo: 0001437749-25-016447 Size: 364 KB Item 2.02: Results of Operations and Financial Condition

Neuropace Inc (NPCE)

New Form 8-K - NeuroPace Inc Filed: 2025-05-13 AccNo: 0001528287-25-000012 Size: 240 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

MiMedx Group Inc (MDXG)

New Form 8-K - MIMEDX GROUP, INC. Filed: 2025-05-13 AccNo: 0001376339-25-000053 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Intensity Therapeutics Inc (INTS)

New Form 8-K - INTENSITY THERAPEUTICS, INC. Filed: 2025-05-13 AccNo: 0001567264-25-000040 Size: 239 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Allogene Therapeutics Inc (ALLO)

New Form 8-K - Allogene Therapeutics, Inc. Filed: 2025-05-13 AccNo: 0001737287-25-000063 Size: 228 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits